FDA allows Aethlon to test Hemopurifier for HCV treatment

06/27/2013 | MedGadget.com

The FDA has granted Aethlon Medical investigational device exemption approval to conduct human feasibility trials of its Hemopurifier system, which is used in extracorporeal blood filtration procedures. The San Diego company will initially test the device in 10 end-stage renal disease patients infected with the hepatitis C virus.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY